Subtype Classification Consortium for Esophageal Squamous cell carcinoma Sensitivity of CROC study (UMIN000008086)

Subtype Classification Consortium for Esophageal Squamous cell carcinoma Sensitivity of CROC study (UMIN000008086) - CROC-G study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029465

Enrollment

100

Registered

2017-10-11

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed squamous cell carcinoma by endoscopic biopsy. 2) Confirmed the lesion of thoracic esophagus (An accessory lesion of EMR absolute criteria may not be localized thoracic esophagus). 3) Clinical stage II/III without T4 in TNM classification (UICC6th). 4) Age more than 20years and less than 75 years. 5) PS(ECOG) of 0 or 1. 6) No previous treatment expect endoscopic resection of esophageal cancer. 7) No previous chemotherapy or radiation therapy for other malignancy. 8) No severe organ failure. 9) Possibility of transthoracic and/or transabdominal curative resection of esophageal cancer. 10) Signed informed consent of the patient for the registration.

Exclusion criteria

Exclusion criteria: 1) An active malignancy other than carcinoma in situ or mucosal carcinoma or a history of other malignancy within the past 5 years. 2) Women who are pregnant, lactating, or wish to become pregnant. 3) Unsuitable mental status and condition for clinical trials. 4) Received continuous steroids (orally or intravenous) administration. 5) Positive HBs antigen. 6) Unstable diabetes mellitus with oral hypoglycemic agent or insulin. 7) Acute myocardial infarction within the past 3 months. 8) Severe complications (COPD, interstitial lung disease, pulmonary fibrosis, heart failure and so on) . 9) Active bacterial or fungous infection(body temperature more than 38.5 degrees and proved bacterial infection by diagnostic imaging or bacteriological examination ) . 10) Any other cases who are regarded as inadequate for study enrollment by the investigator.

Design outcomes

Primary

Measure	Time frame
Subtype classification of esophageal cancer	—

Secondary

Measure	Time frame
Correlation between subtype classification and curative effects	—

Countries

Japan

Contacts

Public ContactChikatoshi Katada

Kitasato University School of Medicine Department of Gastroenterology

ckatada@med.kitasato-u.ac.jp042-778-8111

Outcome results